To establish a novel therapeutic treatment using AHL for diabetic patients, possible interactions of factors such as insulin, leptin and ischemia with the effects of AHL should be investigated, because the pathophysiology of diabetes is complex, and many patients have severe complications [38]. The gene discussed is INS; the disease is diabetes mellitus.